James Ahlers
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About James Ahlers
James Ahlers is recorded as CFO at Cue Biopharma, Inc. (CUE). Cue Biopharma, Inc. reported in an 8-K filed August 3, 2026 that James Ahlers was appointed Chief Financial Officer, effective July 30, 2026.
“the Company’s Board of Directors (the “Board”) appointed James Ahlers as the Company’s Chief Financial Officer, effective as of July 30, 2026 (the “Effective Date”).”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-07-30–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Cue Biopharma, Inc.
Other people whose current roles at this company are on record from its filings.
- Daniel R. Passeri CEO, Board Member
- Dr. Shao-Lee Lin CEO, Board Member
- Lucinda Warren CEO, CFO
- Usman Azam CEO, Board Member
- Kerri Millar CFO
- Colin G. Sandercock General Counsel
- Sumita Ray General Counsel
- Michael Meluzio Chief Accounting Officer
- Daniel Camardo Board Member
- Jill Broadfoot Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.